Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:
Schedule
Product: Proleukin
Active Ingredient: Aldesleukin 18MIU
Dosage Form: Powder for injection
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Biotech Partnership Inc, Emeryville, California, United States of America
Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United Kingdom
Note: This renewed consent is valid for two years from 27 January 2009.
Product: Proleukin
Active Ingredient: Aldesleukin 9MIU
Dosage Form: Powder for injection
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Biotech Partnership Inc, Emeryville, California, United States of America
Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United Kingdom
Note: This renewed consent is valid for two years from 27 January 2009.
Dated this 9th day of January 2009.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).